Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ensysce Biosciences, Inc. - Common Stock
(NQ:
ENSC
)
2.065
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
August 19, 2025
Via
ACCESS Newswire
Ensysce Biosciences Narrows Loss in Q2
August 13, 2025
Via
The Motley Fool
Topics
Intellectual Property
Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates
August 13, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 31, 2025
Via
Benzinga
Ensysce Biosciences Advances Breakthrough Opioid With Built-In Overdose Protection Following Positive FDA Feedback
July 31, 2025
Via
ACCESS Newswire
Ensysce Biosciences Awarded $5.3 Million in Continued NIDA Support to Advance Breakthrough Opioid Overdose Protection
June 04, 2025
Via
ACCESS Newswire
These stocks that are showing activity before the opening bell on Wednesday.
July 23, 2025
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 23, 2025
Via
Benzinga
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
July 16, 2025
Via
ACCESS Newswire
Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
June 24, 2025
Via
ACCESS Newswire
Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025
June 11, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
May 16, 2025
Via
Benzinga
Ensysce Biosciences Reports First Quarter 2025 Financial Results
May 13, 2025
Via
ACCESS Newswire
Ensysce Biosciences Bolsters Management Team with Regulatory Expert
May 12, 2025
Via
ACCESS Newswire
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 24, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 24, 2025
Via
Benzinga
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
April 24, 2025
Via
Benzinga
Top movers in Wednesday's after hours session
April 23, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why
April 23, 2025
Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.
Via
Benzinga
Topics
Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 23, 2025
Via
Benzinga
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 23, 2025
Via
Benzinga
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views
April 23, 2025
Via
Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
April 23, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 23, 2025
Via
Benzinga
Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder
April 23, 2025
Via
ACCESS Newswire
Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled
April 15, 2025
The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.
Via
Stocktwits
Topics
Government
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 15, 2025
Via
Benzinga
Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study
April 15, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.